The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 04, 2017

Filed:

Oct. 29, 2012
Applicant:

The Cleveland Clinic Foundation, Cleveland, OH (US);

Inventors:

Xiaoxia Li, Cleveland, OH (US);

Caini Liu, Cleveland, OH (US);

Junpeng Deng, Cleveland, OH (US);

Thomas A. Hamilton, Cleveland, OH (US);

Jarod Zepp, Cleveland, OH (US);

Assignee:

The Cleveland Clinic Foundation, Cleveland, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); C07K 7/08 (2006.01); C07K 7/06 (2006.01); A61K 38/08 (2006.01); A61K 38/10 (2006.01); A61K 38/16 (2006.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/16 (2013.01); C07K 7/06 (2013.01); C07K 14/00 (2013.01);
Abstract

A method of treating an IL-17 mediated disease in a subject by administering to the subject a therapeutically effective amount of a of a cell-permeable decoy peptide that competitively inhibits binding of the SEFIR domain of IL-17R to the SEFIR domain of Act1. In particular, it has been determined that the αC helix region of the SEFIR domain of both IL-17R and Act1 plays an important role in the association of IL-17R and Act1. To facilitate cell permeation, the decoy peptide is preferably conjugated to a protein transduction domain. Examples of IL-17 mediated diseases include various human and animal inflammatory and autoimmune diseases such as asthma.


Find Patent Forward Citations

Loading…